Loading...
A case report of exceptional clinical response to chemoradiotherapy and tyrosine kinase inhibitors in a patient with EML4-ALK fusion variant 1 non-small cell lung cancer
Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion occurs in approximately 5% of non-small cell lung cancer (NSCLC) cases. Variants 1 and 3a/b are the most common EML4-ALK variants. Emerging evidence indicates that patients with variant 1 and those with v...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815360/ https://ncbi.nlm.nih.gov/pubmed/33489810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1212 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|